Human Cholinergic Receptor, Muscarinic 3 (CHRM3) Peptide (OVA)

Este producto es parte de CHRM - Muscarinic acetylcholine receptor
Product Graph
442€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human Cholinergic Receptor, Muscarinic 3 (CHRM3) Peptide (OVA)
category
Proteins and Peptides
provider
Abbexa
reference
abx651273
tested applications
WB, SDS-PAGE

Description

CHRM3 Peptide (OVA) is a Human protein conjugated to OVA.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Muscarinic Acetylcholine Receptor M3
Origin
Human
Conjugation
OVA
Observed MW
Concentration: Prior to lyophilization: 200 µg/ml
Sequence Fragment: Glu294-Cys311
Expression
Synthetic
Purity
> 90%
Size 1
100 µg
Size 2
200 µg
Size 3
500 µg
Size 4
1 mg
Size 5
5 mg
Form
Lyophilized To keep the original salt concentration, we recommend reconstituting to the original concentration prior to lyophilization (see Concentration) in ddH2O. If a lower concentration is required, dilute in PBS, pH 7.4. If a higher concentration is required, the product can be reconstituted directly in PBS, pH 7.4, though please note that this will change the overall salt concentration. The stock concentration should be between 0.1-1.0 mg/ml. Do not vortex.
Tested Applications
WB, SDS-PAGE
Buffer
Prior to lyophilization: PBS, pH 7.4.
Availability
Shipped within 5-7 working days.
Storage
Store at 2-8 °C for up to one month. Store at -80 °C for up to one year. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Alias
CHRM3,Chrm-3,M3R,cholinergic receptor, muscarinic 3,cholinergic receptor,cholinergic receptor, muscarinic 3, cardiac,M3 receptor,HM3, PBS, EGBRS, m3AChR
Background
Protein CHRM3
Status
RUO
Note
This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

CHRM3 encodes the cholinergic receptor muscarinic 3, another receptor in the muscarinic acetylcholine receptor family that primarily couples to Gq/11 proteins. Upon activation by acetylcholine, CHRM3 stimulates phospholipase C (PLC), leading to increased production of inositol triphosphate (IP3) and diacylglycerol (DAG), which together elevate intracellular calcium ion concentrations and activate downstream signaling pathways. CHRM3 is abundantly expressed in smooth muscle tissues of the gastrointestinal tract, bladder, and lungs, where it plays a key role in mediating smooth muscle contraction. It is critical for processes such as gastrointestinal motility, bronchoconstriction, and urinary bladder contraction. In the CNS, CHRM3 contributes to cognitive function and neuronal signaling. Dysregulation of CHRM3 has been implicated in disorders like overactive bladder syndrome, asthma, and certain types of cancer. Pharmacologically, CHRM3 antagonists, such as antimuscarinics, are used to treat conditions like overactive bladder, while agonists could be explored for potential use in cognitive enhancement. CHRM3 remains a critical target for both autonomic regulation and emerging therapies in neurological disorders and cancer research.

Related Products

EH14692

Human Anti-M3 AChR (Anti-M3 Acetylcholine Receptor Antibody) ELISA Kit

Ver Producto
EH1956

Human CHRM3 (Muscarinic acetylcholine receptor M3) ELISA Kit

Ver Producto
EM2246

Mouse CHRM3 (Muscarinic acetylcholine receptor M3) ELISA Kit

Ver Producto